UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

204 speaker ROLE OF ADJUVANT CHEMOTHERAPY

Radiotherapy and oncology, 2011, Vol.99, p.S79-S80

Sculier, J.P

2011

Volltextzugriff (PDF)

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study

Lung cancer (Amsterdam, Netherlands), 2013-11, Vol.82 (2), p.340-345

2013

Volltextzugriff (PDF)

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

The European respiratory journal, 2001-10, Vol.18 (4), p.705-719

2001

Volltextzugriff (PDF)

The lung cancer patient at the emergency department: A three-year retrospective study

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80 (2), p.203-208

2013

Volltextzugriff (PDF)

Medical anticancer treatment of lung cancer associated with comorbidities: A review

Lung cancer (Amsterdam, Netherlands), 2015-03, Vol.87 (3), p.241-248

2015

Volltextzugriff (PDF)

67O ARE FIRST-LINE PLATINUM-BASED (PT) REGIMENS IMPROVING SURVIVAL IN COMPARISON WITH NON-PLATINUM (NPT) CHEMOTHERAPY (CT) IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)? A META-ANALYSIS (MA) OF RANDOMISED TRIALS

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S31-S31

2013

Volltextzugriff (PDF)

OC-0062: An invidual data metaanalysis of phase II trials of adjuvant or induction chemotherapy for NSCLC treated with chemoRT

Radiotherapy and oncology, 2014, Vol.111, p.S23-S23

2014

Volltextzugriff (PDF)

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working Party

Lung cancer (Amsterdam, Netherlands), 2012-09, Vol.77 (3), p.605-610

2012

Volltextzugriff (PDF)

A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2009-05, Vol.64 (2), p.187-193

2009

Volltextzugriff (PDF)

EGFR, TTF-1 and Mdm2 expression in stage III non-small cell lung cancer: A positive association

Lung cancer (Amsterdam, Netherlands), 2008-10, Vol.62 (1), p.35-44

2008

Volltextzugriff (PDF)

Valproate―doxorubicin: promising therapy for progressing mesothelioma. A phase II study

The European respiratory journal, 2011-01, Vol.37 (1), p.129-135

2011

Volltextzugriff (PDF)

Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53

The European respiratory journal, 2003-05, Vol.21 (5), p.753-758

2003

Volltextzugriff (PDF)

Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49 (1), p.13-23

2005

Volltextzugriff (PDF)

A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2000-07, Vol.29 (1), p.67-73

2000

Volltextzugriff (PDF)

Les inhibiteurs des freins immunitaires (anticorps anti-PD1 et anti-PD-L1), une nouvelle arme thérapeutique dans les cancers bronchiques non à petites cellules

Revue des maladies respiratoires, 2018-02, Vol.35 (2), p.197-205

2018

Volltextzugriff (PDF)

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis

Lung cancer (Amsterdam, Netherlands), 2002-11, Vol.38 (2), p.111-121

2002

Volltextzugriff (PDF)

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

Lung cancer (Amsterdam, Netherlands), 2000-10, Vol.30 (1), p.23-36

2000

Volltextzugriff (PDF)

Score inflammatoire de Glasgow et cancer bronchique : une aide pour hospitaliser aux urgences

Revue des maladies respiratoires, 2016-11, Vol.33 (9), p.759-765

2016

Volltextzugriff (PDF)

A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer

Annals of oncology, 2008-10, Vol.19 (10), p.1691-1697

2008

Volltextzugriff (PDF)

Programme de soins oncologiques (PSO) basé sur des recommandations de pratique clinique (RPC) : application en consultation multidisciplinaire d’oncologie thoracique

Revue des maladies respiratoires, 2015-01, Vol.32, p.A98-A98

2015

Volltextzugriff (PDF)

6524 POSTER Primary tumour standardized uptake value (SUV max) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Staging Project

European journal of cancer supplements, 2007, Vol.5 (4), p.364-365

2007

Volltextzugriff (PDF)

A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer

Annals of oncology, 2007-06, Vol.18 (6), p.1037-1042

2007

Volltextzugriff (PDF)

Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2006-05, Vol.52 (2), p.219-224

2006

Volltextzugriff (PDF)

Is the tolerance to MIP chemotherapy different between English and other European populations?

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6269-6270

2005

Volltextzugriff (PDF)

Les signatures biologiques ont-elles une place dans la prédiction de la réponse et de la survie des CBNPC avancés traités par chimiothérapie de 1re ligne ? Une étude prospective de l’ELCWP

Revue des maladies respiratoires, 2015-01, Vol.32, p.A104-A104

2015

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Englisch
(131)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(67)
Humans
(65)
Oncology
(55)
Biological And Medical Sciences
(51)
Medical Sciences
(51)
Male
(32)
Female
(31)
Middle Aged
(31)
Aged
(30)
Pneumology
(28)
Adult
(27)
Lung Neoplasms - Drug Therapy
(27)
Respiratory System
(27)
Tumors Of The Respiratory System And Mediastinum
(27)
Chemotherapy
(25)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Lung Neoplasms - Pathology
(20)
Lung Neoplasms - Mortality
(17)
Prognosis
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

204 speaker ROLE OF ADJUVANT CHEMOTHERAPY

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

The lung cancer patient at the emergency department: A three-year retrospective study

Medical anticancer treatment of lung cancer associated with comorbidities: A review

67O ARE FIRST-LINE PLATINUM-BASED (PT) REGIMENS IMPROVING SURVIVAL IN COMPARISON WITH NON-PLATINUM (NPT) CHEMOTHERAPY (CT) IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)? A META-ANALYSIS (MA) OF RANDOMISED TRIALS

OC-0062: An invidual data metaanalysis of phase II trials of adjuvant or induction chemotherapy for NSCLC treated with chemoRT

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working Party

A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer

EGFR, TTF-1 and Mdm2 expression in stage III non-small cell lung cancer: A positive association

Valproate―doxorubicin: promising therapy for progressing mesothelioma. A phase II study

Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53

Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature

A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer

Les inhibiteurs des freins immunitaires (anticorps anti-PD1 et anti-PD-L1), une nouvelle arme thérapeutique dans les cancers bronchiques non à petites cellules

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

Score inflammatoire de Glasgow et cancer bronchique : une aide pour hospitaliser aux urgences

A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer

Programme de soins oncologiques (PSO) basé sur des recommandations de pratique clinique (RPC) : application en consultation multidisciplinaire d’oncologie thoracique

A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer

Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer

Is the tolerance to MIP chemotherapy different between English and other European populations?

Les signatures biologiques ont-elles une place dans la prédiction de la réponse et de la survie des CBNPC avancés traités par chimiothérapie de 1re ligne ? Une étude prospective de l’ELCWP

Suchergebnisse filtern